CALIMAN, ENRICO
 Distribuzione geografica
Continente #
EU - Europa 424
NA - Nord America 261
AS - Asia 170
AF - Africa 1
Totale 856
Nazione #
US - Stati Uniti d'America 260
IT - Italia 176
IE - Irlanda 92
HK - Hong Kong 64
PL - Polonia 54
CN - Cina 40
RU - Federazione Russa 38
SE - Svezia 35
JO - Giordania 26
SG - Singapore 25
IN - India 12
AT - Austria 6
CH - Svizzera 5
DE - Germania 5
GB - Regno Unito 4
FI - Finlandia 3
FR - Francia 3
NO - Norvegia 3
VN - Vietnam 2
CA - Canada 1
EG - Egitto 1
PK - Pakistan 1
Totale 856
Città #
Dublin 92
Warsaw 52
Hong Kong 46
Chandler 40
Ashburn 36
Florence 31
Milan 18
Singapore 18
Fairfield 16
Shanghai 16
Boardman 14
New York 12
Seattle 10
Altamura 9
Moscow 9
Rome 9
Woodbridge 9
Lawrence 8
Los Angeles 8
Beijing 7
Pune 7
Brescia 6
Naples 6
Vienna 6
Kent 5
Bern 4
Boston 4
Houston 4
Princeton 4
Zhengzhou 4
Alba 3
Ancona 3
Bremen 3
Mumbai 3
Oslo 3
Recanati 3
San Diego 3
Wilmington 3
Andover 2
Anguillara Sabazia 2
Brusaporto 2
Buffalo 2
Cambridge 2
Carmignano 2
Catania 2
Chennai 2
Cinisello Balsamo 2
Dong Ket 2
Forlì 2
Formia 2
Helsinki 2
Livorno 2
London 2
Mileto 2
Osimo 2
Palermo 2
Paris 2
Rufina 2
San Giovanni Valdarno 2
Scandicci 2
Turin 2
Varese 2
Venice 2
Arezzo 1
Bagno A Ripoli 1
Bisceglie 1
Chicago 1
Falls Church 1
Hamburg 1
Hillsboro 1
Kaluga 1
Krefeld 1
Lahore 1
Lappeenranta 1
Laurel 1
Marcallo con Casone 1
Medford 1
Norwalk 1
Padova 1
Phoenix 1
Sasso Marconi 1
Siena 1
Verona 1
Wandsworth 1
Washington 1
Zurich 1
Totale 607
Nome #
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 155
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 74
Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor) 57
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy 57
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives 55
Induction chemotherapy followed by pleurectomy decortication and hyperthermic intraoperative chemotherapy (Hithoc) for early-stage epitheliod malignant pleural mesothelioma—a prospective report 51
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma 37
Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer 36
In Regard to "Activity of EGFR TKIs in Caucasian Patients With NSCLC Harbouring Potentially Sensitive Uncommon EGFR Mutations" 36
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification 30
Identification of predictive biomarkers of clinical benefits to immunotherapy in pre-treated advanced non-small cell lung cancer: a retrospective observational study 29
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment 28
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population 28
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions 26
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors 25
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study 25
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 22
Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients 22
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 20
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer 18
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 15
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer 15
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients 15
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients 13
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 4
null 3
Totale 896
Categoria #
all - tutte 5.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.621


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 0 3 4 3 9 6 6 6 6 5 6 1
2020/202143 3 7 0 6 3 3 3 4 4 6 0 4
2021/202227 0 2 1 0 0 2 2 5 0 2 3 10
2022/2023302 7 27 5 29 15 52 45 37 47 13 16 9
2023/2024361 10 14 27 19 24 49 24 77 11 19 35 52
2024/202588 64 24 0 0 0 0 0 0 0 0 0 0
Totale 896